KAROLINSKA INSTITUTET

CURRICULUM VITAE
NAME: Mattias Carlstrm
BIRTH DATE: 780407-3372
ADDRESS, PHONE AND E-MAIL
Work Address: Karolinska Institutet, Dept. of Physiology & Pharmacology, Nanna Svartz vg 2,
17177 Stockholm, Phone: +46-(0)8-524 87952, mattias.carlstrom@ki.se
Home Address: Torbjrn Klockares gata 21, 11330, Stockholm, Phone: +46-(0)768-785051

COURSES AND DEGREES

Pharmacy License (Sweden & Norway)
Master of Science in Pharmacy, Uppsala University, Sweden
Master of Pharmaceutical Science, Uppsala University, Sweden
Karolinska Institutet
Grundlggande hgskolepedagogik (GHPV14)
Forskarhandledarutbildning Grundkurs
Formella/operativa chefs- & ledarskapet
Arbetsmiljfrgor kopplat till chefens ansvar

(5 weeks)
(1.5 credits)
(5.0 credits)
(1.5 credits)

-2003
-2003
-2002
-2014
-2013
-2012
-2011

DOCTORAL DEGREE
Uppsala University, Dept. of Medical Cell Biology, Sweden
Ph.D. in Medicine

-2008

Thesis: Development of Salt-Sensitive Hypertension in Hydronephrosis

Supervisor: Professor A. Erik G. Persson

Medicine Licentiate

-2007

Thesis: Hydronephrosis and Hypertension

Supervisor: Professor A. Erik G. Persson

POSTDOC APPOINTMENTS
Postdoc Fellow, Georgetown University, Washington DC, USA
Division of Nephrology & Hypertension

2009 2011

Postdoc Fellow, Karolinska Institutet, Sweden

Department of Physiology & Pharmacology

2008 2009

DOCENT LEVEL COMPETENCE

Application submitted in April (Karolinska Institutet; FyFa)

2015

CURRENT POSITION
Assistant Professor, Group Leader (Karolinska Institutet)
Department of Physiology & Pharmacology

Jan 2012

Adj. Assistant Professor (Georgetown University)

Division of Nephrology & Hypertension, Washington DC, USA

Oct 2011

PRIOR POSITIONS
Quintiles AB, Clinical Trials, Uppsala, Sweden
Technician, Clinical Trials, Phase I and II (Temporary position)

2004-2006

Pharmacist in Chief, Norway (Temporary position)

2003-2006

TIME DEDUCTED FROM ACTIVE RESEARCH TIME

N/A

SELECTED ACADEMIC DISTINCTIONS & OTHER MERITS

i

Prizes & Award

2012: Lewis T. Preston Research Achievement Award, Georgetown University, USA
2011: Top Young Investigator Award, ASN, Kidney Week, Philadelphia, USA
2011: Lewis T. Preston Research Achievement Award, Georgetown University, USA
2011: Fellows Forum Presentation Winner, National Kidney Foundation, NIH, USA
2010: Young Investigator Award Society Free Radical Biology Meeting, Orlando, USA
2010: Fellows Forum Presentation Winner, National Kidney Foundation, NIH, USA
2009: Young Investigator Award 3rd Int. Meeting on the Role of Nitrite in Physiology,
Pathophysiology, and Therapeutics, Sweden
2007: Young Investigator Award - Scand. Physiol. Society Annual Meeting, Oslo, Norway
Invited Presentations
2014: Acta Physiol. Symp. Renal Purinergic Signalling, Sweden
2013: FASEB Conference on Renal Hemodynamics, Saxtons River, VT, USA
2013: 5th Int. Meeting Nitrite & Nitrate in Physiology, Pathophysiology & Therapeutics, PA, USA
2013: Gordon Research Conference (GRC) on Nitric Oxide, Ventura, CA, USA
2012: Acta Physiol. Symp. on Hemodynamic Mechanisms of Acute Kidney Injury, Denmark
2012: Experimental Biology, Regulation of Kidney Functions, San Diego, USA
2011: American Society of Nephrology, Kidney Week, Philadelphia, USA
2011: Nephrology Research Forum, Mississippi Medical Center, Jackson, MS, USA
2011: Nephrology Research Forum, Georgetown University, USA
2011: FASEB - Renal Hemodynamics: Mechanisms of Disease, Saxtons River, VT, USA
Comissions of Trust
2014 Editorial Board of the American Journal of Physiology - Renal Physiology
2012 Editorial Board of the ISRN Nephrology
2011 Editorial Board of the Journal of Nephrology and Therapeutics
2011 Editorial Board of the World Journal of Hypertension
2011 Editorial Board of the World Journal of Nephrology
Cover Images
- Renal Autoregulation in Health and Disease. Physiol Rev 95:405-511; 2015.
Carlstrom M, Wilcox CS, Arendshorst WJ
http://physrev.physiology.org/content/95/2/405
- Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide
synthase-deficient mice. Proc Natl Acad Sci U S A 107:17716-17720; 2010.
Carlstrom M, Larsen FJ, Nystrom T, Hezel M, Borniquel S, Weitzberg E, Lundberg JO
http://www.pnas.org/content/107/41.cover-expansion
Patents
Zhang W, Carlstrom M, Wellstein A. Compositions and treatments of metabolic disorders using fgf
binding protein 3 and fgf19. Georgetown University, Filed Patent on March 14, 2014. ID:
PCT/US2014/026938.

LANGUAGE SKILLS
Swedish (Mother tongue), English (Fluent), German (Good communication skills)

REFERENCES
Christopher S. Wilcox
M.D., Ph.D.
Georgetown University
+1-202-444-9183
+1-877-625-1483
Wilcoxch@georgetown.edu

A. Erik G. Persson
M.D., Ph.D.
Uppsala University
+46 (0)18-4714180
+46 (0)705-321135
Erik.Persson@mcb.uu.se

Jon O. Lundberg
M.D., Ph.D.
Karolinska Institutet
+46 (0)8-52487952
+46 (0)706-987952
Jon.Lundberg@ki.se

ii

SCIENTIFIC PORTFOLIO
1. CURRENT SCIENTIFIC ACTIVITY
Group Leader: Karolinska Institutet, Dept. of Physiology and Pharmacology (100%)
Research Group: Renal & Cardiovascular Research Reactive Oxygen Species and Nitric Oxide
Signaling in Renal, Cardiovascular & Metabolic Functions in Health and Disease
Karolinska Institutet Website:
http://ki.se/en/fyfa/reactive-oxygen-species-and-nitric-oxide-signaling-in-renal-and-cardiovascular-function

Summary of own main research achievements

I have extensive experience from both basic science and clinical studies and I have developed new
concepts and made significant contributions to the field of renal and cardiovascular research, with a
specific focus on nitric oxide regulation and oxidative stress. This is reflected by more than 50
publications in leading international journals in this field. I have published several original articles in
international peer-reviewed scientific journals, as first or senior author, including Proc Natl Acad Sci
USA (IF: 10), Antioxidants & Redox Signaling (IF: 8), Hypertension (IF: 7.6), Cardiovascular
Research (IF: 6), Diabetologia (IF: 7).
After completed postdoctoral studies in USA, I have established my own research group at Karolinska
Institutet (Department of Physiology and Pharmacology). Today I am the principle investigator of a
very successful team, consisting of 3 postdoctoral fellows and 4 PhD students. Over the years I have
developed an extensive network and today my group have ongoing collaborations with world-leading
scientists e.g. in Sweden, Germany, Portugal, Australia, China and USA. These successful
collaborations contribute to the feasibility of my research, but more importantly, they will be
important when translating the results and the understanding from our projects into clinical practice.
My group has access to a broad methodological platform that enables the aspects of integrative
physiology and pharmacology. I have developed or modified unique and sophisticated techniques to
characterize microvascular function in the kidney and in pancreas. These include renal autoregulation
studies in vivo and microperfusion studies in vitro to study vascular reactivity and signaling in renal
afferent arterioles or islet arterioles.
I have received several prizes and been invited as speaker or as chair at many international
conferences of high rank. Moreover, I am currently a member of the editorial boards of American
Journal of Physiology Renal Physiology, ISRN Nephrology, Journal of Nephrology and Therapeutics,
World Journal of Hypertension and World Journal of Nephrology. The contribution to the field of
nephrology and hypertension is also reflected by my recent review about Renal Autoregulation in
Health and Disease. Moreover, together with colleagues in USA (Georgetown University), we have
filed a patent related to a novel treatment of metabolic disorders. A corresponding manuscript is
currently being considered for publication in Cell Metabolism.
I also have collaboration with the community, as evident by membership in health organizations such
as World Action on Salt and Health (WASH) and the National Kidney Foundation (NKF). In these
two organizations we aim to achieve a reduction in dietary salt intake around the world and to enhance
the lives of everyone with, at risk of or affected by kidney disease.
Another achievement, and very important contribution to my field of research, is a comprehensive
review about Renal Autoregulation in Health & Disease published in the prestigious journal
Physiological Reviews with a 5-year impact factor of 38.7. In the same issue our figure was selected
as the cover image. I am the first and corresponding author on this paper, which has been written in
collaboration with two of my colleagues in USA. This work has a clear link to my ongoing research
and emphasizes the important role of the renal microvasculature in development or progression of
hypertension, renal disease and diabetes.

iii

2. SCIENTIFIC PUBLICATIONS
2.1 Bibliometric parameters (2015-04-29)
Web of science (WOS) - Based on 30 articles 2008-2014)
Sum of the Times Cited: 530
Sum of Times Cited without self-citations: 467
Citing Articles: 390
Citing Articles without self-citations: 365
Average Citations per Item: 17.67
h-index: 13
Google Scholar (2015-04-29)
Citations: 807
h-index: 14
i10-index: 22
2.2 List of all original works
Hezel, M., Ming, Liu., Schiffer, TA., Larsen, FJ., Checa, A., Carlstrm, M., Lundberg, JO.,
Weitzberg., W. 2015. Effects of long-term dietary nitrate supplementation in mice. Redox Biology
(Accepted May 26, 2015).
Liu, M., Zollbrecht, C., Peleli, M., Lundberg, JO., Weitzberg, E. & Carlstrm, M. 2015. Nitritemediated renal vasodilatation is increased during ischemic conditions via cGMP-independent
signaling. Free Radic Biol Med. Apr 1;84:154-160. PMID: 25841777
DOI:10.1016/j.freeradbiomed.2015.03.025
Yang, T.,* Peleli, M.,* Zollbrecht, C., Giulietti, A., Terrando, N., Lundberg, JO., Weitzberg, E. &
Carlstrm, M. 2015. Inorganic nitrite attenuates NADPH oxidase-derived superoxide generation in
activated macrophages via a nitric oxide-dependent mechanism. Free Radic Biol Med. Jun;83:159-66
PMID: 25724690. *shared 1st authors
DOI:10.1016/j.freeradbiomed.2015.02.016
Carlstrm, M., Wide, K., Lundvall, M., Cananau, C., Svensson, A., Lundberg, JO., Brny, P. &
Krmar, RT. 2015. Plasma nitrate/nitrite removal by peritoneal dialysis might predispose infants with
low blood pressure to cerebral ischemia. Clinical Kidney Journal. Apr;8(2):215-8. PMID: 25815180
DOI:10.1093/ckj/sfv009
Al-Mashhadi, A., Nevus, T., Stenberg, A., Karanikas, B., Persson, AEG., Carlstrom, M.* & Whlin,
N.* 2015 Surgical treatment reduces blood pressure in children with unilateral congenital
hydronephrosis. J Pediatr Urol. Mar 11. pii: S1477-5131(15)00046-7. PMID: 25819380 *shared senior
authors. DOI:10.1016/j.jpurol.2015.01.008
Patzak, A., Carlstrom, M., Sendeski, M. M., Lai, E. Y., Liu, Z. Z., Sallstrom, J., Floge, J., Heintz, B.,
Jankowski, J. & Jankowski, V. 2015. Diadenosine pentaphosphate modulates glomerular arteriolar
tone and glomerular filtration rate. Acta Physiol (Oxf), 213, 285-93.
Lu, Y., Zhang, R., Ge, Y., Carlstrom, M., Wang, S., Fu, Y., Cheng, L., Wei, J., Roman, R. J., Wang,
L., Gao, X. & Liu, R. 2015. Identification and function of A3 receptor in afferent arteriole. Am J
Physiol Renal Physiol, DOI: 10.1152/ajprenal.00422.2014
Gao, X., Yang, T., Liu, M., Peleli, M., Zollbrecht, C., Weitzberg, E., Lundberg, J. O., Persson, A. E. &
Carlstrom, M. 2015. NADPH oxidase in the renal microvasculature is a primary target for blood
pressure-lowering effects by inorganic nitrate and nitrite. Hypertension, 65, 161-70.
Gao, X., Peleli, M., Zollbrecht, C., Patzak, A., Persson, A. E. & Carlstrom, M. 2015. Adenosine A1
receptor-dependent and independent pathways in modulating renal vascular responses to angiotensin
II. Acta Physiol (Oxf), 213, 268-76.

iv

Carlstrom, M., Liu, M., Yang, T., Zollbrecht, C., Huang, L., Peleli, M., Borniquel, S., Kishikawa, H.,
Hezel, M., Persson, A. E., Weitzberg, E. & Lundberg, J. O. 2014. Cross-talk Between Nitrate-NitriteNO and NO Synthase Pathways in Control of Vascular NO Homeostasis. Antioxid Redox Signal. 2014
Feb 6. [Epub ahead of print]
Terrando, N., Gomez-Galan, M., Yang, T., Carlstrom, M., Gustavsson, D., Harding, R. E., Lindskog,
M. & Eriksson, L. I. 2013. Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline.
FASEB J, 27, 3564-71.
Shen, X., Carlstrom, M., Borniquel, S., Jadert, C., Kevil, C. G. & Lundberg, J. O. 2013. Microbial
regulation of host hydrogen sulfide bioavailability and metabolism. Free Radic Biol Med, 60, 195-200.
Sallstrom, J., Peuckert, C., Gao, X., Larsson, E., Nilsson, A., Jensen, B. L., Onozato, M. L., Persson,
A. E., Kullander, K. & Carlstrom, M. 2013. Impaired EphA4 signaling leads to congenital
hydronephrosis, renal injury, and hypertension. Am J Physiol Renal Physiol, 305, F71-9.
Nguy, L., Johansson, M. E., Grimberg, E., Lundgren, J., Teerlink, T., Carlstrom, M., Lundberg, J. O.,
Nilsson, H. & Guron, G. 2013. Rats with adenine-induced chronic renal failure develop low-renin,
salt-sensitive hypertension and increased aortic stiffness. Am J Physiol Regul Integr Comp Physiol,
304, R744-52.
Carlstrom, M., Brown, R. D., Yang, T., Hezel, M., Larsson, E., Scheffer, P. G., Teerlink, T.,
Lundberg, J. O. & Persson, A. E. 2013. L-arginine or tempol supplementation improves renal and
cardiovascular function in rats with reduced renal mass and chronic high salt intake. Acta Physiol
(Oxf), 207, 732-41.
Lai, E. Y., Solis, G., Luo, Z., Carlstrom, M., Sandberg, K., Holland, S., Wellstein, A., Welch, W. J. &
Wilcox, C. S. 2012. p47(phox) is required for afferent arteriolar contractile responses to angiotensin II
and perfusion pressure in mice. Hypertension, 59, 415-20.
Gao, X., Patzak, A., Sendeski, M., Scheffer, P. G., Teerlink, T., Sallstrom, J., Fredholm, B. B.,
Persson, A. E. & Carlstrom, M. 2011. Adenosine A(1)-receptor deficiency diminishes afferent
arteriolar and blood pressure responses during nitric oxide inhibition and angiotensin II treatment. Am
J Physiol Regul Integr Comp Physiol, 301, R1669-81.
Carlstrom, M., Wilcox, C. S. & Welch, W. J. 2011. Adenosine A2A receptor activation attenuates
tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthase. Am J Physiol
Renal Physiol, 300, F457-64.
Carlstrom, M., Persson, A. E., Larsson, E., Hezel, M., Scheffer, P. G., Teerlink, T., Weitzberg, E. &
Lundberg, J. O. 2011. Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries,
and reduces blood pressure in salt-induced hypertension. Cardiovasc Res, 89, 574-85.
Brown, R. D., Turner, A. J., Carlstrom, M., Persson, A. E. & Gibson, K. J. 2011. Tubuloglomerular
feedback response in the prenatal and postnatal ovine kidney. Am J Physiol Renal Physiol, 300,
F1368-74.
Sallstrom, J., Carlstrom, M., Olerud, J., Fredholm, B. B., Kouzmine, M., Sandler, S. & Persson, A. E.
2010. High-protein-induced glomerular hyperfiltration is independent of the tubuloglomerular
feedback mechanism and nitric oxide synthases. Am J Physiol Regul Integr Comp Physiol, 299,
R1263-8.
Carlstrom, M., Wilcox, C. S. & Welch, W. J. 2010. Adenosine A(2) receptors modulate
tubuloglomerular feedback. Am J Physiol Renal Physiol, 299, F412-7.
Carlstrom, M., Larsen, F. J., Nystrom, T., Hezel, M., Borniquel, S., Weitzberg, E. & Lundberg, J. O.
2010. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide
synthase-deficient mice. Proc Natl Acad Sci U S A, 107, 17716-20.

Carlstrom, M., Lai, E. Y., Ma, Z., Steege, A., Patzak, A., Eriksson, U. J., Lundberg, J. O., Wilcox, C.
S. & Persson, A. E. 2010. Superoxide dismutase 1 limits renal microvascular remodeling and
attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide
bioavailability. Hypertension, 56, 907-13.
Carlstrom, M. 2010. Seasonal variation may affect clinical diagnosis of metabolic syndrome.
Hypertens Res, 33, 531-3.
Ma, Z., Steege, A., Patzak, A., Lai, EY., Eriksson UJ., Lundberg, JO., Persson, AEG., Carlstrom M.
2009. Critical role of cuznsod in regulating renal microcirculation and in angiotensin ii-induced
hypertension. Circulation,120:S1111
Petersson, J.*, Carlstrom, M*., Schreiber, O., Phillipson, M., Christoffersson, G., Jagare, A., Roos, S.,
Jansson, E. A., Persson, A. E., Lundberg, J. O. & Holm, L. 2009. Gastroprotective and blood pressure
lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic Biol Med, 46,
1068-75. *shared 1st authors
Lai, E. Y., Patzak, A., Persson, A. E. & Carlstrom, M. 2009. Angiotensin II enhances the afferent
arteriolar response to adenosine through increases in cytosolic calcium. Acta Physiol (Oxf), 196, 43545.
Carlstrom, M., Wentzel, P., Skott, O., Persson, A. E. & Eriksson, U. J. 2009. Angiogenesis inhibition
causes hypertension and placental dysfunction in a rat model of preeclampsia. J Hypertens, 27, 82937.
Carlstrom, M., Lai, E. Y., Ma, Z., Patzak, A., Brown, R. D. & Persson, A. E. 2009. Role of NOX2 in
the regulation of afferent arteriole responsiveness. Am J Physiol Regul Integr Comp Physiol, 296,
R72-9.
Carlstrom, M., Brown, R. D., Sallstrom, J., Larsson, E., Zilmer, M., Zabihi, S., Eriksson, U. J. &
Persson, A. E. 2009. SOD1 deficiency causes salt sensitivity and aggravates hypertension in
hydronephrosis. Am J Physiol Regul Integr Comp Physiol, 297, R82-92.
Turner, A. J., Brown, R. D., Carlstrom, M., Gibson, K. J. & Persson, A. E. 2008. Mechanisms of
neonatal increase in glomerular filtration rate. Am J Physiol Regul Integr Comp Physiol, 295, R91621.
Sallstrom, J., Carlstrom, M., Jensen, B. L., Skott, O., Brown, R. D. & Persson, A. E. 2008. Neuronal
nitric oxide synthase-deficient mice have impaired renin release but normal blood pressure. Am J
Hypertens, 21, 111-6.
Carlstrom, M., Lai, E. Y., Steege, A., Sendeski, M., Ma, Z., Zabihi, S., Eriksson, U. J., Patzak, A. &
Persson, A. E. 2008. Nitric oxide deficiency and increased adenosine response of afferent arterioles in
hydronephrotic mice with hypertension. Hypertension, 51, 1386-92.
Carlstrom, M., Development of salt-sensitive hypertension in hydronephrosis, Acta Universitatis
Upsaliensis; Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of
Medicine, 324; 2008 (ISBN 978-91-554-7137-8) http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8586
#

Carlstrom, M., Brown, R. D., Edlund, J., Sallstrom, J., Larsson, E., Teerlink, T., Palm, F., Wahlin, N.
& Persson, A. E. 2008. Role of nitric oxide deficiency in the development of hypertension in
hydronephrotic animals. Am J Physiol Renal Physiol, 294, F362-70.
#

Carlstrom, M., Wahlin, N., Skott, O. & Persson, A. E. 2007. Relief of chronic partial ureteral
obstruction attenuates salt-sensitive hypertension in rats. Acta Physiol (Oxf), 189, 67-75.
#

Carlstrom, M., Sallstrom, J., Skott, O., Larsson, E., Wahlin, N. & Persson, A. E. 2007.
Hydronephrosis causes salt-sensitive hypertension and impaired renal concentrating ability in mice.
Acta Physiol (Oxf), 189, 293-301.

vi

Carlstrom, M., Sallstrom, J., Skott, O., Larsson, E. & Persson, A. E. 2007. Uninephrectomy in young
age or chronic salt loading causes salt-sensitive hypertension in adult rats. Hypertension, 49, 1342-50.
#

Carlstrom, M., Wahlin, N., Sallstrom, J., Skott, O., Brown, R. & Persson, A. E. 2006. Hydronephrosis
causes salt-sensitive hypertension in rats. J Hypertens, 24, 1437-43.
#

denotes publications included in the applicants dissertation

2.3 The ten most-cited publications

Petersson, J.*, Carlstrom, M*., Schreiber, O., Phillipson, M., Christoffersson, G., Jagare, A., Roos, S.,
Jansson, E. A., Persson, A. E., Lundberg, J. O. & Holm, L. 2009. Gastroprotective and blood pressure
lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic Biol Med, 46,
1068-75. Times Cited: 68 (WOS); 93 (Google Scholar)
Carlstrom, M., Larsen, F. J., Nystrom, T., Hezel, M., Borniquel, S., Weitzberg, E. & Lundberg, J. O.
2010. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide
synthase-deficient mice. Proc Natl Acad Sci USA, 107, 17716-20. Times Cited: 68 (WOS); 112
(Google Scholar)
Carlstrom, M., Persson, A. E., Larsson, E., Hezel, M., Scheffer, P. G., Teerlink, T., Weitzberg, E. &
Lundberg, J. O. 2011. Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries,
and reduces blood pressure in salt-induced hypertension. Cardiovasc Res, 89, 574-85. Times Cited:
58 (WOS); 83 (Google Scholar)
Lundberg, J. O., Carlstrom, M., Larsen, F. J. & Weitzberg, E. 2011. Roles of dietary inorganic nitrate
in cardiovascular health and disease. Cardiovasc Res, 89, 525-32. Times Cited: 55 (WOS);
114(Google Scholar)
Carlstrom, M., Lai, E. Y., Ma, Z., Patzak, A., Brown, R. D. & Persson, A. E. 2009. Role of NOX2 in
the regulation of afferent arteriole responsiveness. Am J Physiol Regul Integr Comp Physiol, 296,
R72-9. Times Cited: 26 (WOS); 35 (Google Scholar)
Carlstrom, M., Sallstrom, J., Skott, O., Larsson, E. & Persson, A. E. 2007. Uninephrectomy in young
age or chronic salt loading causes salt-sensitive hypertension in adult rats. Hypertension, 49, 1342-50.
Times Cited: 25 (WOS) ; 45 (Google Scholar)
Carlstrom, M., Lai, E. Y., Ma, Z., Steege, A., Patzak, A., Eriksson, U. J., Lundberg, J. O., Wilcox, C.
S. & Persson, A. E. 2010. Superoxide dismutase 1 limits renal microvascular remodeling and
attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide
bioavailability. Hypertension, 56, 907-13. Times Cited: 21 (WOS); 26 (Google Scholar)
Carlstrom, M., Brown, R. D., Edlund, J., Sallstrom, J., Larsson, E., Teerlink, T., Palm, F., Wahlin, N.
& Persson, A. E. 2008. Role of nitric oxide deficiency in the development of hypertension in
hydronephrotic animals. Am J Physiol Renal Physiol, 294, F362-70. Times Cited: 17 (WOS); 20
(Google Scholar)
Carlstrom, M., Wahlin, N., Sallstrom, J., Skott, O., Brown, R. & Persson, A. E. 2006. Hydronephrosis
causes salt-sensitive hypertension in rats. J Hypertens, 24, 1437-43. Times Cited: 16 (WOS); 21
(Google Scholar)
Carlstrom, M., Wilcox, C. S. & Welch, W. J. 2011. Adenosine A2A receptor activation attenuates
tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthase. Am J Physiol
Renal Physiol, 300, F457-64. Times Cited: 14 (WOS); 18 (Google Scholar)

2.4 The ten most important publications

Yang, T.,* Peleli, M.,* Zollbrecht, C., Giulietti, A., Terrando, N., Lundberg, JO., Weitzberg, E. &
Carlstrm, M. 2015. Inorganic nitrite attenuates NADPH oxidase-derived superoxide generation in
activated macrophages via a nitric oxide-dependent mechanism. Free Radic Biol Med. Jun;83:159-66
PMID: 25724690. *shared 1st authors

vii

Carlstrom, M., Wilcox, CS., Arendshorst, WJ. 2015. Renal autoregulation in health and disease.
Physiological Reviews, 95(2):405-511.
Gao, X., Yang, T., Liu, M., Peleli, M., Zollbrecht, C., Weitzberg, E., Lundberg, J. O., Persson, A. E. &
Carlstrom, M. 2015. NADPH oxidase in the renal microvasculature is a primary target for blood
pressure-lowering effects by inorganic nitrate and nitrite. Hypertension, 65, 161-70.
Carlstrom, M., Liu, M., Yang, T., Zollbrecht, C., Huang, L., Peleli, M., Borniquel, S., Kishikawa, H.,
Hezel, M., Persson, A. E., Weitzberg, E. & Lundberg, J. O. 2014. Cross-talk Between Nitrate-NitriteNO and NO Synthase Pathways in Control of Vascular NO Homeostasis. Antioxid Redox Signal. 2014
Feb 6. [Epub ahead of print]
Carlstrom, M., Wilcox, C. S. & Welch, W. J. 2011. Adenosine A2A receptor activation attenuates
tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthase. Am J Physiol
Renal Physiol, 300, F457-64.
Petersson, J.*, Carlstrom, M*., Schreiber, O., Phillipson, M., Christoffersson, G., Jagare, A., Roos, S.,
Jansson, E. A., Persson, A. E., Lundberg, J. O. & Holm, L. 2009. Gastroprotective and blood pressure
lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic Biol Med, 46,
1068-75.
Carlstrom, M., Larsen, F. J., Nystrom, T., Hezel, M., Borniquel, S., Weitzberg, E. & Lundberg, J. O.
2010. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide
synthase-deficient mice. Proc Natl Acad Sci U S A, 107, 17716-20.
Carlstrom, M., Persson, A. E., Larsson, E., Hezel, M., Scheffer, P. G., Teerlink, T., Weitzberg, E. &
Lundberg, J. O. 2011. Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries,
and reduces blood pressure in salt-induced hypertension. Cardiovasc Res, 89, 574-85.
Carlstrom, M., Lai, E. Y., Ma, Z., Patzak, A., Brown, R. D. & Persson, A. E. 2009. Role of NOX2 in
the regulation of afferent arteriole responsiveness. Am J Physiol Regul Integr Comp Physiol, 296,
R72-9.
Carlstrom, M., Sallstrom, J., Skott, O., Larsson, E. & Persson, A. E. 2007. Uninephrectomy in young
age or chronic salt loading causes salt-sensitive hypertension in adult rats. Hypertension, 49, 1342-50.

2.5 List of general articles and book chapters

Reviews
Carlstrom, M., Wilcox, CS., Arendshorst, WJ. 2015. Renal autoregulation in health and disease.
Physiological Reviews, 95(2):405-511.
Persson, A. E., Lai, E. Y., Gao, X., Carlstrom, M. & Patzak, A. 2013. Interactions between adenosine,
angiotensin II and nitric oxide on the afferent arteriole influence sensitivity of the tubuloglomerular
feedback. Front Physiol, 4, 187.
Lundberg, J. O., Carlstrom, M., Larsen, F. J. & Weitzberg, E. 2011. Roles of dietary inorganic nitrate
in cardiovascular health and disease. Cardiovasc Res, 89, 525-32.
Carlstrom, M. 2011. Seasonal variation in metabolic syndrome components: how much do they
influence the diagnosis of metabolic syndrome. Current Cardiovascular Risk Reports, 5 (1), 29-37,
DOI: 10.1007/s12170-010-0139-z
Carlstrom, M. 2010. Causal link between neonatal hydronephrosis and later development of
hypertension. Clin Exp Pharmacol Physiol, 37, e14-23.
Book Chapter in
Extracellular Nucleotides in the Regulation of Kidney Functions, Frontiers in Physiology (2015),
Edited by: Bellamkonda K Kishore, Robert John Unwin, Volker Vallon, Helle Prtorius. ISBN: 9782-88919-504-6. DOI 10.3389/978-2-88919-504-6

viii

2.6 List of all other scientific works

Editorials, Letters and Commentaries
Persson, A. E. & Carlstrom, M. 2015. Renal purinergic signalling in health and disease. Acta Physiol
(Oxf), 213, 805-807
Persson, AE, Sallstrom, J., Carlstrm M. 2013. Unlocking the factors behind hypertension Science
Technology & Innovation Projects. 2013 Nov 4. http://www.projectsmagazine.eu.com
Carlstrom, M. 2011. Response to sex of the animal impacts responses to angiotensin ii (ang ii),
oxidative stress and nitric oxide (NO) bioavailability. Hypertension, 57, Issue 5,
doi:10.1161/HYPERTENSIONAHA.111.171165
Carlstrom, M. & Persson, A. E. 2009. Important role of NAD(P)H oxidase 2 in the regulation of the
tubuloglomerular feedback. Hypertension, 53, 456-7.

3. INTERNATIONAL SCIENTIFIC CONGRESSES (2011-2014)

3.1 Invited speaker or chair
-Acta Physiol. Symp. Renoprotection, Stockholm, Sweden, March, 2016
Abnormal renal autoregulation in hypertension and chronic kidney disease
-Acta Physiol. Symp. Renal Purinergic Signalling in Health and Disease, Uppsala, Sweden, June 2014
Tubuloglomerular Feedback Regulation - Role of Adenosine Receptors & Nitric Oxide Synthases
-FASEB Summer Conference on Renal Hemodynamics, Saxtons River, VT, USA, June, 2013
Mechanisms of autoregulation, tubuloglomerular feedback and myogenic control
- Fifth International Meeting On the Role of Nitrite and Nitrate In Physiology, Pathophysiology, and
Therapeutics, Pittsburgh, PA, May, 2013
-Gordon Research Conference (GRC) on Nitric Oxide, Ventura, CA, February, 2013
Importance of reactive nitrogen and oxygen species in renal and cardiovascular function
-Copenhagen, Oct 2012, Symposium on Hemodynamic Mechanisms of Acute Kidney Injury
-ISIC Scientific Committee Meeting, Karolinska Institutet, May, 2012
Adenosine Receptors in the Kidney - Renal Autoregulation, Vascular Regulation & Hypertension
-Experimental Biology, San Diego, April, 2012
Extracellular Nucleotides and Nucleosides in the Regulation of Kidney Functions
-Uppsala University, Renal Function Meeting, Uppsala, Dec, 2011
Oxidativ stress and Renal Blood Flow Regulation
-Uppsala University, Research Seminars, Oct, 2011
Adenosine-Mediated-oxidative stress modulates Tubuloglomerular Feedback and Arteriolar
Reactivity
- Nephrology Research Forum, University of Mississippi Medical Center, Jackson, MS, June, 2011
Novel Aspects of Adenosine Receptors in Regulation of Tubuloglomerular Feedback
-Uppsala University, Research Seminars, May, 2011
Oxidative Stress and Nitric Oxide Deficiency in Renal and Cardiovascular Disease
-Nephropathies - Research Seminar, AstraZeneca, Sweden, May, 2011
Oxidative Stress and Nitric Oxide Deficiency in Renal and Cardiovascular Disease
-Nephrology Research Seminar, Georgetown University, February, 2011
Oxidative Stress and Nitric Oxide Deficiency in Renal and Cardiovascular Disease
-FyFa Forum Research Seminar, Karolinska Institutet, December, 2010
Renal oxidative stress and nitric oxide deficiency in renal and cardiovascular disease
-FASEB, Summer Research Conference, Vermont Academy, Saxtons River, VT, USA, July, 2010
Adenosine A2 Receptors Modulate Tubuloglomerular Feedback

3.2 Oral presentations of own accepted abstracts (2011-2014)

ix

Yang T & Carlstrom M. Therapeutic effects with adenosine A3 receptor inhibition in a renal and
cardiovascular disease via modulation of inflammation and oxidative stress. High Blood Pressure
Research (HBPR), Scientific Session, San Francisco, CA, USA, 2014
Peleli M, Al-Mashhadi A & Carlstrm M. Renal Denervation Attenuates Salt-Sensitive Hypertension
and Oxidative Stress in Rats with Unilateral Hydronephrosis. High Blood Pressure Research (HBPR),
Scientific Session, San Francisco, CA, USA, 2014
Carlstrom M. Interaction between adenosine, angiotensin II, superoxide and NO in regulating
tubuloglomerular feedback. FASEB Summer Research Conference, Renal Hemodynamics, Saxton
River, VT, USA, 2013
Yang T & Carlstrom M. Stimulation of a novel nitrate-nitrite-NO pathway attenuates angiotensin IIinduced arteriolar contraction by reducing NADPH oxidase-mediated oxidative stress. FASEB
Summer Research Conference on Renal Hemodynamics, Saxton River, VT, USA, 2013
Gao X & Carlstrm M. Abrogation of adenosine A1 receptor signalling improves metabolic regulation
in aging and obesity. FASEB Summer Research Conference on Renal Hemodynamics, Saxton River,
VT, USA, 2013
Gao X, Sandberg M, Fredholm BB, Persson AEG, Jansson L, Carlstrm M. Adenosine A1 receptor
deficiency improves glucose metabolism and attenuates vasoconstriction of islet arterioles to
angiotensin II. American Diabetes Association Scientific, Scientific Session, Chicago, IL, 2013
Carlstrom M. Adenosine Receptors Modulate Angiotensin II-Mediated Effects on Tubuloglomerular
Feedback. Fellows Research Forum, National Kidney Foundation, NIH, Washington, DC, USA,
2011/2012
Carlstrom M. Wilcox C, Welch W. Adenosine-Mediated Tubuloglomerular Feedback Responses are
Modulated by eNOS in the Afferent Arteriole. American Society of Nephrology, Kidney Week,
Philadelphia, 2011
Carlstrom M. Adenosine A2 Receptors Modulate Tubuloglomerular Feedback. Fellows Research
Forum, National Kidney Foundation, NIH, Washington, DC, USA, 2010/2011

4. RESEARCH FUNDING OBTAINED IN THE PAST FIVE YEARS

4.1 External research funding obtained in international or national competition as
principal applicant
- Swedish Heart & Lung Foundation (Research Grant; #20140448)
2015-2017: 1.800.000 SEK
- KI Foundations (Research Grant)
2014-2015: 180.000 SEK
- Jeanssons Stiftelse (Research Grant; #JS2013-0064)
2014-2015: 300.000 SEK
- KID Grant 2 (PhD Funding, Karolinska Institutet)
2014-2017: 1.500.000 SEK
- KID Grant 1 (PhD Funding, Karolinska Institutet)
2013-2016: 1.500.000 SEK
- The Swedish Research Council; VR (Research Grant; #K2012-99X-21971-01-3)
2012-2014: 2.100.000 SEK
- Swedish Heart & Lung Foundation (Research Grant; #20110589)
2012-2014: 1.800.000 SEK
-Jeanssons Stiftelse (Research Grant; #JS2011-0212)
2012-2013: 320.000 SEK
-Lars Hiertas Foundation (Research Grant)

2011-2012: 40.000 SEK

-The Swedish Society for Medical Research (Postdoc grant)
2010-2011: 270.000 SEK
-Wenner-Gren Foundations (Postdoc grant)
2009-2010: 300.000 SEK
-Magnus Bergvalls Foundation (Research Grant)
2009-2010: 100.000 SEK
-The Swedish Society of Medicine (Research Grant)
2009-2010: 90.000 SEK

4.2 External research funding obtained in international or national competition as coapplicant

-STINT - Joint Brazilian-Swedish Research Collaboration (#2014-5512)
2014-2017: 794.000 tkr (co-applicant with Prof. Erik Persson, MCB, Uppsala University)
-The Swedish Research Council (VR, #K2009-64X-03522-38-2), co-applicant with Dr AEG Persson
2011-2013: 700 000 SEK/year

-Swedish Heart & Lung Foundation (#20100183), co-applicant with Dr AEG Persson
2011-2012: 400 000 SEK/year
-HRH Crown Princess Lovisa's Foundation, co-applicant with Dr AEG Persson
2011-2012: 90 000 SEK

4.3 Significant other research funding received (donation, grant in local competition
e.g. ALF project) as principal applicant
- Bodossaki Foundation (Athen, Greece), PhD Funding Scholorship
2013-2016: 320.000 SEK

4.4 Significant other research funding received (donation, grant in local competition
e.g. ALF project) as co-applicant
N/A
5. SCIENTIFIC COLLABORATIONS
International Collaborators of Interest
Dr Christopher Wilcox, William Welch & Anton Wellstein (Georgetown University, Washington
DC): Oxidative stress, hypertension and diabetes
Dr Enyin Lai, Zhejiang University, China: multi-photon confocal techniques in afferent arterioles
Dr Ruisheng Liu (University of Mississippi Medical Center, Jackson, MS): Macula densa studies
Dr. Andreas Patzak & Mauricio Sendeski (Charit University, Berlin): Renal microvasculature
Dr Tom Teerlink & Peter G. Scheffer (VU University Medical Centre, Amsterdam): Oxidative stress
Dr Ole Sktt & Boye Jensen (University of Southern Denmark, Odense): Kidney function
Dr Maristela L. Onozato (Massachusetts General Hospital, Boston, USA): Renal morphology
Kenneth A. Jacobson (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda,
USA): Adenosine receptor signaling (Novel and highly selective adenosine analogous)

National Collaborators of Interest

Dr Rafael Krmar, Jakob Stenman, Thomas Gustafson, Peter Brny, Annika Wernersson
(Karolinska University Hospital): Clinical studies: Renal disease & Hypertension
Dr. Tryggve Nevus, Peter Flacker, Anders Stenbck (Uppsala Akademiska Hospital): Clinical
studies: Renal disease & Hypertension
Dr Leif Jansson (Uppsala University): Adenosine and islet beta cell function in diabetes
Erik Persson (Uppsala University): Renal nitric oxide synthase function in hypertension
Dr Jon Lundberg & Eddie Weitzberg (Karolinska Institutet): Nitrate-nitrite-NO pathway
Dr Bertil Fredholm (Karolinska Institute): Consultant on Adenosine receptors

xi

 Dr Robert Harris (Karolinska Institute): FACS analysis and immune cell regulation
Dr Erik Larsson (Uppsala University): Histology, morphology and immunohistochemistry

6. SUPERVISION OF GRADUATE STUDENTS

6.1 PhD candidates supervised up to the defence of the candidates doctoral thesis, with
the applicant serving as main supervisor
N/A

6.2 PhD candidates supervised up to the defence of the candidates doctoral thesis, with
the applicant serving as co-supervisor
Xiang Gao (Uppsala University, Dept. of Medical Cell Biology)
I am the senior author on three out four publications in the thesis

6.3 Students supervised up to their licentiate degree, with the applicant serving as main
supervisor
N/A

6.4 Students supervised up to their licentiate degree, with the applicant serving as cosupervisor
N/A

6.5 Ongoing supervision of a PhD candidate, with the applicant serving as main
supervisor
Karolinska Institutet, Dept. of Physiology and Pharmacology
- Maria Peleli (2013-09-23)
- Zhuge Zhengbing (Application in Process (expected start of PhD Program in Sept 2015)

6.6 Ongoing supervision of a PhD candidate, with the applicant serving as co-supervisor
Ammar Farman M.D. (Uppsala University, Dept. of Women's and Children's Health, Paediatric
Surgery) 2012Peter Flacker M.D. (Uppsala University, Dept. of Women's and Children's Health, Paediatric Surgery)
Application in Process (expected start of PhD Program in Sept 2015)

6.7 Postdoc supervision

- Christa Zollbrecht (PhD) Karolinska Institutet
- Ting Yang (MD, PhD) Karolinska Institutet
- Ming Liu (MD) Karolinska Institutet
- Liyue Huang (PhD) Uppsala University

Jul 2013 Jan 2012 Feb 2012 2012-2013

6.8 Supervision of other researchers who have defended a thesis

N/A

6.9 Ongoing careers of holders of earlier PhDs and of postdocs

N/A

7. THESIS EVALUATIONS
7.1 Serving as thesis opponent
N/A

7.2 Serving as a member of a thesis examination committee

Final defense:
Date: 2013-08-28
Candidate: Peng Xiaoxiao
Title: Study of Biochemical and Cellular Functional Differences Between

xii

Selenoproteins and their Cys-containing counterparts-Focus on mammalian Thioredoxin Reductase 1

Supervisor: Elias Arnr
Institution: Karolinska Institutet, Department of Medical Biochemistry and Biophysics
Half-time defense:
Date: 2014-02-28
Candidate: Norhashimah Abu Seman
Title: Searching for Biomarkers of Diabetic Nephropathy in Malaysian Type 2 Diabetes Patients
Supervisor: Harvest F. Gu
Institution: Karolinska Institutet, Department of Molecular Medicine and Surgery, Karolinska
University Hospital & Cardiovascular, Diabetes and Nutrition Research Centre, Institute for Medical
Research, Kuala Lumpur, Malaysia
Date: 2014-02-14
Candidate: Irina Pader
Title: Thioredoxin system regulated cellular signalling
Supervisor: Elias Arnr
Institution: Karolinska Institutet, Department of Medical Biochemistry and Biophysics
Date: 2013-06-18
Candidate: Peng Xiaoxiao
Title: Study of Biochemical and Cellular Functional Differences Between
Selenoproteins and Their Cys-containing Counterparts-Focus on Mammalian Thioredoxin Reductase 1
Supervisor: Elias Arnr
Institution: Karolinska Institutet, Department of Medical Biochemistry and Biophysics
Date: 2013-05-15
Candidate: Arnar Rafnsson
Title: Endothelial dysfunction in atherosclerosis and type 2 diabetes: role of endothelin-1
Supervisor: John Pernow
Institution: Karolinska Institutet, Dept. of Medicine, Cardiology Unit, Karolinska University Hospital
Date: 2013-03-06
Candidate: Ferdinand Xiankeng Choong
Title: Tissue microbiology - an integrated approach for intra vital studies of host-pathogen interactions
Supervisor: Agneta Richter Dahlfors
Institution: Karolinska Institutet, Dept. of Neuroscience (Medical Nanoscience Center)

7.3 External thesis reviewer

N/A

8. EVALUATION OF OTHERS WORK

8.1 Serving as reviewer of candidates proposed for academic positions
N/A

8.2 Serving as reviewer for international evaluations

N/A

8.3 Evaluator of research applications in international competition

- The Portuguese Foundation for Science and Technology (FCT), External Reviewer, 2012
- Experimental and Translational Medicine Research (ETMR) in Scotland, Chief Scientist Office
Committee, Scottish Government, Edinburgh, External Reviewer, 2011

8.4 Evaluator of research applications in national competition

N/A

xiii

8.5 Evaluator of major research grant applications in local competition

N/A

8.6 Editor of scientific journals

N/A

8.8 Member of an editorial board

2014 Editorial Board of the American Journal of Physiology - Renal Physiology
2012 Editorial Board of the ISRN Nephrology
2011 Editorial Board of the Journal of Nephrology and Therapeutics
2011 Editorial Board of the World Journal of Hypertension
2011 Editorial Board of the World Journal of Nephrology

8.8 Referee for scientific journals

Invited reviewer for more than 20 different scientific journals, among them many highly ranked
journals:
-

Acta Physiol (Oxf)

American J. Physiology: Renal & Regulatory, Integrative and Comparative Physiology
Antioxidants and Redox Signaling
Biochemia Medica
Biomembranes
Circulation
Circulation Research
Clinical and Experimental Pharmacology and Physiology
European J. of Pharmacology
Expert Opinion on Pharmacotherapy
Experimental Physiology
Hypertension
Hypertension Research
International J. of Developmental Neuroscience
J. Pathology
J. Physiology
Kidney International
Life Sciences
Pediatric Nephrology
Pflugers Archive-European J. Physiology
Pharmacological Research
Proc Natl Acad Sci

8.8 Reviewer or advisor for other scientific bodies

N/A

8.9 Other relevant evaluation assignments

Evaluation of Scientific Research Articles
The Faculty of 1000 Medicine: Associate member of Nephrology (Hemodynamics, Vascular Biology
& Hypertension Secondary to Kidney Disease) with more than 15 evaluations and recommendation.
http://f1000.com/prime/thefaculty/member/1674616855171111?show=50
Collaboration with the Community:
-World Action on Salt and Health (WASH)
As a member of this organization we aim to achieve a reduction in dietary salt intake around the
world from the current intake of 10-15g/day to the WHO target of 5g/day. This fall in salt intake and
the resulting fall in blood pressure would lead to major reductions in both incidents of, and deaths
from Cardiovascular Disease (CVD). We have discussions with the food industry and government and
also try to reach out to the households. This spring WASH Sweden organized a joint meeting together
with Livsmedelsverket in Uppsala to discuss the risks associated with high salt intake, and how to act.
Related Media Sources:
Dagens Nyheter (Publicerad: 2010-12-24):

xiv

http://www.dn.se/debatt/med-mindre-salt-i-maten-blir-vi-mycket-friskare/
Uppsala Nya Tidning; UNT (Publicerad: 2011-03-23):
http://www.unt.se/inc/print/natverk-vill-minska-saltintag--1292473-default.aspx
Salt Seminarium, Livsmedelsverket & WASH (Publicerat: 23 mars 2011):
http://www.slv.se/upload/dokument/mat/kostrad/ref_seminar_salt_livsmedel_23%20mars_11.pdf
-National Kidney Foundation (NKF)
As a member of this organization we aim to enhance the lives of everyone with, at risk of or affected
by kidney disease. NKF, a major voluntary nonprofit health organization, is dedicated to preventing
kidney and urinary tract diseases, improving the health and well-being of individuals and families
affected by kidney disease and increasing the availability of all organs for transplantation. NKF has
been providing help and hope to kidney patients and their families since 1950. Today, with local
offices across the country, NKF is meeting the growing public health challenge of chronic kidney
disease with a range of vital programs and services for the public, patients and healthcare
professionals.

INTERNATIONAL VISITING RESEARCH FELLOWSHIPS

Adj. Assistant Professor (Georgetown University, Division of Nephrology and Hypertension,

Washington DC, USA) Oct 2011

10 SCIENTIFIC DISTINCTIONS
Prizes & Award
2012: Lewis T. Preston Research Achievement Award, Georgetown University, USA
2011: Top Young Investigator Award, ASN, Kidney Week, Philadelphia, USA
2011: Lewis T. Preston Research Achievement Award, Georgetown University, USA
2011: Fellows Forum Presentation Winner, National Kidney Foundation, NIH, USA
2010: Young Investigator Award Society Free Radical Biology Meeting, Orlando, USA
2010: Fellows Forum Presentation Winner, National Kidney Foundation, NIH, USA
2009: Young Investigator Award 3rd Int. Meeting on the Role of Nitrite in Physiology,
Pathophysiology, and Therapeutics, Sweden
2007: Young Investigator Award - Scand. Physiol. Society Annual Meeting, Oslo, Norway
Invited Presentations
2014: Acta Physiol. Symp. Renal Purinergic Signalling, Sweden
2013: FASEB Conference on Renal Hemodynamics, Saxtons River, VT, USA
2013: 5th Int. Meeting Nitrite & Nitrate in Physiology, Pathophysiology & Therapeutics, PA, USA
2013: Gordon Research Conference (GRC) on Nitric Oxide, Ventura, CA, USA
2012: Acta Physiol. Symp. on Hemodynamic Mechanisms of Acute Kidney Injury, Denmark
2012: Experimental Biology, Regulation of Kidney Functions, San Diego, USA
2011: American Society of Nephrology, Kidney Week, Philadelphia, USA
2011: Nephrology Research Forum, Mississippi Medical Center, Jackson, MS, USA
2011: Nephrology Research Forum, Georgetown University, USA
2011: FASEB - Renal Hemodynamics: Mechanisms of Disease, Saxtons River, VT, USA
Comissions of Trust
2014 Editorial Board of the American Journal of Physiology - Renal Physiology
2012 Editorial Board of the ISRN Nephrology
2011 Editorial Board of the Journal of Nephrology and Therapeutics
2011 Editorial Board of the World Journal of Hypertension
2011 Editorial Board of the World Journal of Nephrology
Cover Images
- Renal Autoregulation in Health and Disease. Physiol Rev 95:405-511; 2015.
Carlstrom M, Wilcox CS, Arendshorst WJ
http://physrev.physiology.org/content/95/2/405
- Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide
synthase-deficient mice. Proc Natl Acad Sci U S A 107:17716-17720; 2010.

xv

Carlstrom M, Larsen FJ, Nystrom T, Hezel M, Borniquel S, Weitzberg E, Lundberg JO

http://www.pnas.org/content/107/41.cover-expansion

xvi